Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situ
-
* Corresponding author: E Shelley Hwang shelley.hwang@ucsfmedctr.org
BMC Cancer 2009, 9:285 doi:10.1186/1471-2407-9-285
Pre-publication versions of this article and reviewers' reports
| Resubmission - Version 2 | Manuscript | Author's comment | 22 Jan 2009 |
| Reviewer's Report | Laura Collins | 19 Feb 2009 | |
| Reviewer's Report | Jeremy Thomas | 18 Mar 2009 | |
| Reviewer's Report | Jeremy Thomas | 18 Mar 2009 | |
| Reviewer's Report | Paul Mintz | 18 Mar 2009 | |
| Reviewer's Report | Nigel Bundred | 30 Mar 2009 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 09 Jun 2009 |
| Reviewer's Report | Paul Mintz | 02 Jul 2009 | |
| Resubmission - Version 4 | Manuscript | Author's comment | 06 Jul 2009 |
| Editorial acceptance | 10 Jul 2009 | ||
| Published | 18 Aug 2009 |